[{"AccountsPayableCurrent_0_Q2_USD":8545000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":-985000.0,"PaymentsToAcquireOtherPropertyPlantAndEquipment_2_Q2_USD":1000000.0,"PaymentsToAcquireInvestments_2_Q2_USD":24373000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":2675000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":109000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":61000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1624000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-10000.0,"OtherAssetsCurrent_0_Q2_USD":4598000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1155000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2700000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1027000.0,"OperatingLeaseLiability_0_Q2_USD":2650000.0,"OperatingIncomeLoss_2_Q2_USD":-38798000.0,"OperatingIncomeLoss_1_Q2_USD":-17959000.0,"OperatingExpenses_2_Q2_USD":39059000.0,"OperatingExpenses_1_Q2_USD":18193000.0,"NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_1_Q2_USD":1.1,"NetIncomeLoss_2_Q2_USD":-39025000.0,"OtherAssetsNoncurrent_0_Q2_USD":2670000.0,"NetIncomeLoss_1_Q2_USD":-18067000.0,"PreferredStockValue_0_Q2_USD":0.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":21772000.0,"TreasuryStockValue_0_Q2_USD":7518000.0,"TreasuryStockShares_0_Q2_shares":1165000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":8000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":111000.0,"StockIssuedDuringPeriodSharesNewIssues_1_Q2_shares":88000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":137233000.0,"StockholdersEquity_0_Q2_USD":137233000.0,"ShortTermLeaseCommitmentAmount_0_Q2_USD":1000000.0,"ShortTermInvestments_0_Q2_USD":28614000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.01,"ShareBasedCompensation_2_Q2_USD":5637000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":16924000.0,"RoyaltyIncomeNonoperating_2_Q2_USD":261000.0,"Revenues_2_Q2_USD":261000.0,"Revenues_1_Q2_USD":234000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1439043000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":22866000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10257000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":0.0,"RealizedInvestmentGainsLosses_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1201000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":5947000.0,"RoyaltyIncomeNonoperating_1_Q2_USD":234000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":144451000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-47039000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":14249000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-39024000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-18077000.0,"CommonStockValue_0_Q2_USD":146000.0,"CommonStockSharesIssued_0_Q2_shares":145640000.0,"CommonStockSharesAuthorized_0_Q2_shares":225000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-36376000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":89887000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":89887000.0,"AvailableForSaleSecurities_0_Q2_USD":28614000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":123258000.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"AssetImpairmentCharges_1_Q2_USD":0.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":29000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":31000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2786000.0,"AdditionalPaidInCapital_0_Q2_USD":1583653000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-5000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4746000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":12595000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":12595000.0,"AccountsReceivableNetCurrent_0_Q2_USD":159000.0,"Assets_0_Q2_USD":171672000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-3586000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":79000.0,"LongTermDebtCurrent_0_Q2_USD":11675000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":1623000.0,"LiabilitiesCurrent_0_Q2_USD":32815000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":171672000.0,"Liabilities_0_Q2_USD":34439000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":444000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1163000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":531000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":544000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":486000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":370000.0,"DebtInstrumentFairValue_0_Q2_USD":12100000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3094000.0,"InterestPaidNet_2_Q2_USD":307000.0,"InterestExpense_2_Q2_USD":336000.0,"InterestExpense_1_Q2_USD":169000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-451000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-261000.0,"IncreaseDecreaseInInventories_2_Q2_USD":0.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-236000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-14707000.0,"Goodwill_0_Q2_USD":44543000.0,"EarningsPerShareBasic_2_Q2_USD":-0.27,"EarningsPerShareBasic_1_Q2_USD":-0.13,"InvestmentsFairValueDisclosure_0_Q2_USD":118501000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":143917000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]